الفهرس | Only 14 pages are availabe for public view |
Abstract The implication of combo-RT, in intermediate-risk prostate cancer patients, is associated improvement in the bRFS, but this is also accompanied by an increase in the GU toxicity. This improvement in the bRFS is statistically significant in case of the unfavorable sub-#103;-#114;-#111;-#117;-#112; of br intermediate-risk patients, whereas it is insignificant with the favorable subgroup. SO, these data suggest the possible therapeutic benefit of using intensified local therapy with the unfavorable intermediate-risk prostate cancer patients. |